Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil

被引:16
|
作者
Castilho, E. C. D. [1 ]
Reis, A. M. M. [2 ]
Borges, T. L. [1 ]
Siqueira, L. D. C. [3 ]
Miasso, A. I. [1 ]
机构
[1] Univ Sao Paulo, Ribeirao Preto Nursing Sch, Psychiat Nursing & Human Sci Dept, Ribeirao Preto, SP, Brazil
[2] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil
[3] Grande Dourados Univ Hosp, Dourados, MS, Brazil
关键词
aged; drug interactions; drug therapy; health of the elderly; patient safety; polypharmacy; MEDICATION RECONCILIATION; PSYCHIATRIC-PATIENTS; INAPPROPRIATE MEDICATIONS; PSYCHOTROPIC MEDICATIONS; COHORT; PREVALENCE; FLUOXETINE; ADMISSIONS; MANAGEMENT; PAROXETINE;
D O I
10.1111/jpm.12431
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Accessible Summary What is known on the subject? Older individuals constitute an increasing proportion of the population, and therefore, are the major consumers of drugs. The elderly, especially those with mental disabilities, frequently develop chronic diseases and start using numerous drugs. Drug-drug interactions (DDIs) are a major clinical problem in the elderly population, and previous studies have focused only on antidepressants and others types of drugs used to treat mental health conditions. What this article adds to existing knowledge? This study shows that in hospitalized elderly patients with mental disorders (aged 60-69years), polypharmacy (5 drugs) and the use of drugs that act on the cardiovascular, respiratory and nervous systems can lead to potential drug-drug interactions. Moreover, it was reported that the prevalence of drug-drug interactions in elderly patients with mental disorders was high during their hospitalization in a public hospital in Brazil. What are the implications for practice? Nurses should know the factors associated with drug-drug interactions in hospitalized elderly patients with mental disorders to choose appropriate strategies for avoiding treatment failure and adverse events in patients. Abstract Introduction Despite the impact on patient safety and the fact that prevalence is higher in older patients, previous research did not analyse drug-drug interactions (DDIs) in view of nursing care of elderly psychiatric patients. Aim To identify potential drug-drug interactions and polypharmacy in prescriptions of aged inpatients with psychiatric disorders and analyse associated factors. Methods In this retrospective cross-sectional study, we analysed the medical records of institutionalized patients diagnosed with psychiatric disorders (n=94), aged >60years, and prescribed multiple medications. Drug prescriptions were checked at admission, midway through and the last prescription. Factors associated with DDI occurrence were assessed using multivariable logistic regression analysis. Results A DDI prevalence potential of 67.0%, 74.5% and 80.8% occurred in patients at admission, midway through hospitalization and the last prescription, respectively. Most of the prescribed drugs were nervous system agents. A high percentage of serious and contraindicated potential DDIs occurred. Age between 60 and 69years, use of cardiovascular and respiratory system drugs, and the number of medications contributed significantly to DDI. Implications for mental health nursing Knowledge on the factors associated with DDIs in patients with mental disorders can contribute to the improvement of effectiveness and safety of nursing care.
引用
收藏
页码:3 / 13
页数:11
相关论文
共 50 条
  • [1] A Study on Polypharmacy and Potential Drug-Drug Interactions among Elderly Patients Admitted in Department of Medicine of a Tertiary Care Hospital in Puducherry
    Salwe, Kartik Janardan
    Kalyansundaram, Dharani
    Bahurupi, Yogesh
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016, 10 (02) : FC6 - FC10
  • [2] Polypharmacy and potential drug-drug interactions in emergency department patients in the Caribbean
    Dookeeram, Darren
    Bidaisee, Satesh
    Paul, Joanne F.
    Nunes, Paula
    Robertson, Paula
    Maharaj, Vidya Ramcharitar
    Sammy, Ian
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (05) : 1119 - 1127
  • [4] Potential drug-drug interactions in elderly patients presenting with syncope
    Gaeta, TJ
    Fiorini, M
    Ender, K
    Bove, J
    Diaz, J
    JOURNAL OF EMERGENCY MEDICINE, 2002, 22 (02): : 159 - 162
  • [5] Prevalence of polypharmacy, drug-drug interactions, and inappropriate prescription in elderly patients with urological cancers
    Carballeira, Clara Castro
    Alda, Maria Ibanez
    Lanza, Maria
    Sanchez, Laura
    Sotelo, Marta
    Cacho, Diego
    Gomez, Borja
    Duran, Ignacio
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] The incidence of potential drug-drug interactions based on degree of polypharmacy
    Hirsh, EL
    Trimarco, TW
    Ward, MF
    Lee, D
    Nozzolillo, M
    Sama, AE
    ANNALS OF EMERGENCY MEDICINE, 2003, 42 (04) : S25 - S26
  • [7] NIMODIPINE - POTENTIAL FOR DRUG-DRUG INTERACTIONS IN THE ELDERLY
    MUCK, W
    AHR, G
    KUHLMANN, J
    DRUGS & AGING, 1995, 6 (03) : 229 - 242
  • [8] Evaluation of potential drug-drug interactions and polypharmacy in hospitalized COVID-19 patients
    Kilit, Turkan Pasali
    Ozyigit, Filiz
    Erarslan, Sertas
    Onbasi, Kevser
    AFRICAN HEALTH SCIENCES, 2022, 22 (04) : 597 - 606
  • [9] Polypharmacy in hematology and oncology patients and the resulting prevalence of potential drug-drug interactions (DDI)
    Metzke, B.
    Fink, G.
    Hieke, S.
    Jung, M.
    Hug, M. J.
    Engelhardt, M.
    ONKOLOGIE, 2012, 35 : 76 - 76
  • [10] Polypharmacy and potential drug-drug or food-drug interactions in atrial fibrillation
    Dobrica, E. C.
    Gaman, M. A. Mihnea Alexandru
    Cozma, M. A.
    Diaconu, C. C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 310 - 310